Dupuytren’s Contracture vs Trigger Finger UK Diagnosis

Part of our complete guide to Dupuytren's Contracture.

Last updated: 6 August 2026

Dupuytren’s contracture and trigger finger are distinct hand conditions that can cause similar symptoms of finger stiffness and reduced mobility. Dupuytren’s contracture UK patients experience progressive thickening of the palmar fascia causing fingers to curl permanently, whilst trigger finger involves tendon inflammation causing fingers to catch or lock when moving. Understanding the differences is crucial for appropriate treatment selection and optimal outcomes.

Understanding dupuytren's contracture and trigger finger

Dupuytren’s contracture affects the connective tissue beneath the palm’s skin, forming nodules and cords that gradually pull fingers into a bent position. This progressive condition primarily affects the ring and little fingers, with patients unable to fully straighten affected digits. The NHS describes Dupuytren’s contracture as a condition where thickened tissue forms cords that pull the fingers towards the palm.

Trigger finger, conversely, results from inflammation of the tendons that bend the fingers, causing them to catch or lock in a bent position. Unlike Dupuytren’s contracture, trigger finger typically allows normal finger straightening once the catching sensation is overcome. The condition affects the flexor tendons and their surrounding sheaths, creating a mechanical restriction rather than a structural contracture.

Key diagnostic differences

Several clinical features distinguish these hand contracture conditions. Dupuytren’s contracture presents with visible palm nodules and cords, gradual onset over months or years, and inability to place the hand flat on a table surface. The condition typically affects men over 50 with Northern European heritage and may have genetic components.

Trigger finger manifests as finger catching during movement, pain at the palm’s base, morning stiffness, and a clicking sensation when bending or straightening fingers. Symptoms often worsen with repetitive gripping activities and may affect any finger, though the thumb, ring, and middle fingers are most commonly involved.

Causes and risk factors

Dupuytren’s contracture develops through complex genetic and environmental factors. Additional risk factors include diabetes, smoking, alcohol consumption, epilepsy medications, and hand trauma. The condition shows marked ethnic predisposition, affecting people of Scandinavian, Irish, and Scottish descent more frequently.

Trigger finger treatment becomes necessary when inflammation develops in the flexor tendon sheath, often due to repetitive hand use, diabetes, rheumatoid arthritis, or hypothyroidism. Women aged 40-60 experience trigger finger more commonly than men, particularly those with occupations requiring repetitive gripping motions.

Demographics and Prevalence

UK epidemiological data shows Dupuytren’s contracture affects approximately 4% of the general population, rising to 20% in men over 65. Scottish and Northern English populations demonstrate higher prevalence rates due to Viking ancestry genetic markers. The condition rarely affects people of African or Asian descent.

Trigger finger affects 2-3% of the general population, with lifetime risk reaching 10% in diabetic patients. The condition shows no significant ethnic variation but demonstrates clear gender differences, with women experiencing trigger finger 2-6 times more frequently than men.

Clinical assessment and diagnosis

Dupuytren’s contracture UK diagnosis relies on clinical examination findings rather than imaging studies. GMC-registered hand surgeons assess for Hueston’s tabletop test, where patients cannot place their hand flat on a surface due to finger contracture. Nodule palpation, cord identification, and contracture measurement using standardised angles provide diagnostic confirmation.

Trigger finger diagnosis involves observing the characteristic catching motion during finger flexion and extension. Practitioners assess trigger severity using classification systems ranging from Grade 1 (triggering without locking) to Grade 4 (fixed flexion contracture). Physical examination reveals tenderness over the A1 pulley at the palm’s base and may demonstrate palpable nodular thickening.

When to seek specialist assessment

Patients should consult healthcare providers when finger stiffness interferes with daily activities, progressive finger bending prevents normal hand function, or pain significantly impacts quality of life. Early assessment enables appropriate treatment selection and may prevent progression to more severe contractures requiring complex surgical intervention.

The NHS recommends seeking medical attention for trigger finger when conservative measures fail to provide symptom relief after 6 weeks, fingers lock frequently, or multiple fingers become affected. Diabetic patients should seek earlier assessment due to increased complication risks and variable treatment responses.

Treatment options and pathways

Dupuytren’s contracture treatment selection depends on contracture severity, progression rate, and functional impairment. Conservative management offers limited benefit, with physiotherapy and splinting providing minimal improvement for established contractures. Injectable treatments include collagenase enzyme therapy and needle aponeurotomy for appropriate candidates.

Surgical intervention remains the gold standard for significant Dupuytren’s contracture, with fasciectomy procedures offering excellent outcomes when performed by experienced hand surgeons. The NICE guidelines support collagenase injection use for specific contracture patterns, whilst recognising surgical fasciectomy as the definitive treatment option.

Trigger finger treatment approaches

Trigger finger treatment follows a stepped approach beginning with activity modification, anti-inflammatory medications, and finger splinting. Corticosteroid injections provide effective symptom relief for 60-80% of patients, particularly those without diabetes or multiple finger involvement.

Surgical trigger finger release offers definitive treatment when conservative measures fail, with success rates exceeding 95%. The procedure involves dividing the A1 pulley to eliminate mechanical restriction, typically performed under local anaesthetic as a day-case procedure.

What to expect recovery timelines and outcomes

Dupuytren’s contracture recovery varies significantly depending on treatment modality. Collagenase injection patients typically experience improvement within 24-72 hours, with full assessment possible after 6 weeks. Some patients may require manipulation procedures to achieve optimal finger extension.

Surgical fasciectomy recovery involves initial immobilisation for 48-72 hours, followed by progressive mobilisation over 6-12 weeks. Hand therapy matters in optimising outcomes, with patients requiring splinting and exercise programmes to maintain finger extension and prevent recurrence.

Trigger finger recovery expectations

Trigger finger treatment with corticosteroid injection may provide symptom relief within days, though maximum benefit typically occurs over 4-6 weeks. Success rates vary from 60-90% depending on patient factors, with diabetic patients experiencing lower success rates and shorter symptom-free periods.

Surgical trigger finger release offers immediate mechanical improvement, with patients able to move fingers normally following local anaesthetic resolution. Return to normal activities typically occurs within 2-4 weeks, though heavy manual work may require 6-8 weeks for complete recovery.

Cost considerations and NHS access

NHS funding for Dupuytren’s contracture treatment depends on contracture severity and functional impact. Most Clinical Commissioning Groups fund treatment when contracture exceeds 30 degrees or significantly impairs hand function. Private treatment costs range from £2,000-£5,000 for surgical procedures, depending on complexity and surgeon experience.

Trigger finger treatment receives standard NHS funding for both injection and surgical interventions. Private trigger finger injection costs typically range from £300-£600, whilst surgical release procedures cost £1,500-£3,000 privately. Many patients choose private treatment to avoid waiting lists and access specialist hand surgery centres.

Choosing the right treatment pathway

Treatment selection requires careful consideration of individual patient factors, contracture severity, and personal preferences. Patients with early-stage Dupuytren’s contracture may benefit from observation and monitoring, whilst progressive disease typically requires intervention to prevent severe deformity.

Trigger finger patients should initially attempt conservative management including activity modification and splinting. Persistent symptoms warrant corticosteroid injection, with surgical intervention reserved for injection failures or severe cases with multiple finger involvement.

Finding qualified practitioners

Patients should seek treatment from GMC-registered practitioners with specialist hand surgery training. The British Society for Surgery of the Hand maintains directories of qualified surgeons, whilst the British Association of Aesthetic Plastic Surgeons provides surgeon verification services.

NHS hand surgery services offer comprehensive care pathways with multidisciplinary team involvement including hand therapists and occupational therapists. Private practice may offer reduced waiting times but requires careful practitioner selection to ensure appropriate qualifications and experience levels.

Frequently asked questions

Can Dupuytren’s contracture and trigger finger occur together?

Yes, patients can develop both conditions simultaneously, particularly those with diabetes or other risk factors. Each condition requires separate assessment and treatment, though some surgical procedures can address both issues during the same operation. Combined treatment planning requires specialist hand surgery expertise to optimise outcomes.

How can I tell the difference between early Dupuytren’s contracture and trigger finger?

Early Dupuytren’s contracture typically presents with palm nodules and gradual finger stiffness without catching sensations. Trigger finger causes distinctive clicking or locking during finger movement with pain at the palm’s base. If uncertain, seek assessment from a hand specialist for accurate diagnosis and appropriate treatment planning.

Will my symptoms worsen without treatment?

Dupuytren’s contracture typically progresses gradually over years, though progression rates vary significantly between individuals. Trigger finger may improve with activity modification but often persists or worsens without specific treatment. Early intervention generally provides better outcomes and may prevent progression to more complex problems.

Are there any home remedies that actually work for these conditions?

Limited evidence supports home remedies for either condition, though gentle stretching and activity modification may help trigger finger symptoms. Dupuytren’s contracture rarely responds to conservative measures once contracture develops. Patients should focus on proven treatments and avoid unsubstantiated remedies that may delay appropriate care.

What are the risks of leaving these conditions untreated?

Untreated Dupuytren’s contracture may progress to severe finger deformity, making surgical correction more complex and less predictable. Untreated trigger finger can lead to permanent finger stiffness and joint problems. Both conditions significantly impact quality of life and hand function when left untreated.

How do I know if I need surgery rather than injection treatment?

Surgery becomes necessary for Dupuytren’s contracture when contracture exceeds 30 degrees or significantly impairs function. Trigger finger surgery is indicated when injection treatment fails or symptoms severely impact daily activities. Specialist assessment helps determine the most appropriate treatment approach based on individual circumstances.

Can these conditions recur after treatment?

Dupuytren’s contracture recurs in 10-15% of surgical cases, typically developing in different hand areas rather than the original site. Trigger finger recurrence after injection is common, particularly in diabetic patients, whilst surgical release rarely recurs. Regular follow-up helps detect early recurrence and enables prompt intervention.

Will I need time off work after treatment?

Time off work depends on treatment type and occupation. Injection treatments typically require minimal time away from work, whilst surgical procedures may need 2-6 weeks depending on job requirements. Manual workers generally require longer recovery periods than office workers. Discuss specific work demands with your treating surgeon for personalised advice.